Berman Tabacco Announces Investigation of TransMedics Group, Inc. (™DX) regarding Scorpion Capital’s claims By Investing.com
BOSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) — Berman Tabacco announces that it is investigating potential securities law violations by TransMedics Group (NASDAQ: ), Inc. (TransMedics or the Company) (NASDAQ:™DX).
About the investigation
On January 10, 2025, Bloomberg reported that TransMedics shares fell as much as 13% after Scorpion Capital said it was shorting the transplant therapy company’s stock.
Contact
If you have information about Scorpion Capital’s report or would like more information about our investigation, please click here: Shareholder Contact | Berman Tabacco or contact us at 800-516-9926 or law@bermantabacco.com.
About Berman Tabacco
Since 1982, our firm has handled hundreds of complex securities and antitrust cases. The firm and its attorneys have received recognition for their work on behalf of plaintiffs, including Chambers USA, Benchmark Litigation, which ranked the firm highly recommended and among the top ten plaintiffs, The Legal 500, US News & World Report-Best Lawyers, The Daily Journal , Lawdragon, Who’s Who Legal and Super Lawyers. The company has offices in Boston, Massachusetts and San Francisco, California.
For more information, click here or contact us at 800-516-9926 or law@bermantabacco.com.
This notice may constitute advertising for lawyers.
Past results do not guarantee future results.
Jay Eng, Esq.
Berman Tabacco
One Freedom Square
Boston, Massachusetts
(800) 516-9926
Email: law@bermantabacco.com
